Systemic Amyloidosis and Kidney Transplantation: An Update

Amyloidosis is a heterogeneous disorder characterized by abnormal protein aggregate deposition that often leads to kidney involvement and end -stage kidney disease. With advancements in diagnostic techniques and treatment options, the prevalence of patients with amyloidosis requiring chronic dialysis has increased. Kidney transplantation is a promising avenue for extending survival and enhancing quality of life in these patients. However, the complex and heterogeneous nature of amyloidosis presents challenges in determining optimal referral timing for transplantation and managing post -transplantation course. This review focuses on recent developments and outcomes of kidney transplantation for amyloidosis-related end -stage kidney disease. This review also aims to guide clinical decision -making and improve management of patients with amyloidosis-associated kidney disease, offering insights into optimizing patient selection and post -transplant care for favorable outcomes. Semin Nephrol 44:151496 (c) 2024 Elsevier Inc. All rights reserved.